202 related articles for article (PubMed ID: 35295948)
21.
Hamada T; Zhang X; Mima K; Bullman S; Sukawa Y; Nowak JA; Kosumi K; Masugi Y; Twombly TS; Cao Y; Song M; Liu L; da Silva A; Shi Y; Gu M; Li W; Koh H; Nosho K; Inamura K; Keum N; Wu K; Meyerhardt JA; Kostic AD; Huttenhower C; Garrett WS; Meyerson M; Giovannucci EL; Chan AT; Fuchs CS; Nishihara R; Giannakis M; Ogino S
Cancer Immunol Res; 2018 Nov; 6(11):1327-1336. PubMed ID: 30228205
[TBL] [Abstract][Full Text] [Related]
22.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
23. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
24. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
25. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade.
Wu Y; Wu J; Chen T; Li Q; Peng W; Li H; Tang X; Fu X
Dig Dis Sci; 2018 May; 63(5):1210-1218. PubMed ID: 29508166
[TBL] [Abstract][Full Text] [Related]
26. Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer.
Wangmo D; Gates TJ; Zhao X; Sun R; Subramanian S
Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250876
[TBL] [Abstract][Full Text] [Related]
27. The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review.
Ranjbar M; Salehi R; Haghjooy Javanmard S; Rafiee L; Faraji H; Jafarpor S; Ferns GA; Ghayour-Mobarhan M; Manian M; Nedaeinia R
Cancer Cell Int; 2021 Apr; 21(1):194. PubMed ID: 33823861
[TBL] [Abstract][Full Text] [Related]
28. Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.
Feng YY; Zeng DZ; Tong YN; Lu XX; Dun GD; Tang B; Zhang ZJ; Ye XL; Li Q; Xie JP; Mao XH
PLoS One; 2019; 14(4):e0215088. PubMed ID: 30951563
[TBL] [Abstract][Full Text] [Related]
29. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.
Shariati A; Razavi S; Ghaznavi-Rad E; Jahanbin B; Akbari A; Norzaee S; Darban-Sarokhalil D
Infect Agent Cancer; 2021 Jun; 16(1):41. PubMed ID: 34108031
[TBL] [Abstract][Full Text] [Related]
30. Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity.
Wu J; Li Q; Fu X
Transl Oncol; 2019 Jun; 12(6):846-851. PubMed ID: 30986689
[TBL] [Abstract][Full Text] [Related]
31. Fusobacterium nucleatum, the communication with colorectal cancer.
Luo K; Zhang Y; Xv C; Ji J; Lou G; Guo X; Chen M; Zhang Y; Wei H; Guo M; Huang R; Yu S
Biomed Pharmacother; 2019 Aug; 116():108988. PubMed ID: 31112873
[TBL] [Abstract][Full Text] [Related]
32. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.
Liu L; Tabung FK; Zhang X; Nowak JA; Qian ZR; Hamada T; Nevo D; Bullman S; Mima K; Kosumi K; da Silva A; Song M; Cao Y; Twombly TS; Shi Y; Liu H; Gu M; Koh H; Li W; Du C; Chen Y; Li C; Li W; Mehta RS; Wu K; Wang M; Kostic AD; Giannakis M; Garrett WS; Hutthenhower C; Chan AT; Fuchs CS; Nishihara R; Ogino S; Giovannucci EL
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1622-1631.e3. PubMed ID: 29702299
[TBL] [Abstract][Full Text] [Related]
33.
Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
[No Abstract] [Full Text] [Related]
34. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
[TBL] [Abstract][Full Text] [Related]
35. Association between colorectal cancer and expression levels of miR-21, miR-17-5P, miR-155 genes and the presence of Fusobacterium nucleatum in biopsy samples obtained from Iranian patients.
Bostanshirin N; Hajikhani B; Vaezi AA; Kermanian F; Sameni F; Yaslianifard S; Goudarzi M; Dadashi M
Infect Agent Cancer; 2023 Mar; 18(1):14. PubMed ID: 36859379
[TBL] [Abstract][Full Text] [Related]
36.
Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
[TBL] [Abstract][Full Text] [Related]
37. Targeting Programmed
Ganesan K; Guo S; Fayyaz S; Zhang G; Xu B
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635333
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-31 induced by
Tang B; Lu X; Tong Y; Feng Y; Mao Y; Dun G; Li J; Xu Q; Tang J; Zhang T; Deng L; He X; Lan Y; Luo H; Zeng L; Xiang Y; Li Q; Zeng D; Mao X
iScience; 2023 May; 26(5):106770. PubMed ID: 37216106
[TBL] [Abstract][Full Text] [Related]
39. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
40. Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts.
Wang H; Li Z; Ou S; Song Y; Luo K; Guan Z; Zhao L; Huang R; Yu S
Front Mol Biosci; 2022; 9():884839. PubMed ID: 35836930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
